Exudative Retinal Detachment Following Chimeric Antigen Receptor T-Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia

被引：3

作者：

Khanna, Saira ^{[1
]}

Mackin, Anna G. ^{[1
]}

Dao, David T. ^{[1
]}

Komati, Rahul ^{[2
]}

Morocco, Perry C. ^{[3
]}

LaBelle, James L. ^{[4
]}

Shah, Hassan A. ^{[1
]}

Blair, Michael P. ^{[1
,5
]}

机构：

[1] Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA

[2] Georgia Retina, Atlanta, GA USA

[3] Univ Chicago, Comer Childrens Hosp, Dept Pediat, Chicago, IL 60637 USA

[4] Univ Chicago, Dept Pediat, Corner Childrens Hosp, Sect Hematol Oncol Stem Cell Transplantat, Chicago, IL 60637 USA

[5] Retina Consultants Ltd, 2454 E Dempster St,Suite 400, Des Plaines, IL 60016 USA

来源：

OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2022年 / 53卷 / 02期

关键词：

D O I：

10.3928/23258160-20220124-01

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Chimeric antigen receptor (CAR) T-cell therapy has become a novel approach in the treat-ment of many hematologic malignancies. However, ocular adverse effects have not been well described. This report presents a case of a pediatric patient with relapsed B-cell acute lymphoblastic leukemia with ocular involvement treated with CAR T-cell therapy who developed an exudative retinal de-tachment likely secondary to an inflammatory re-sponse to CAR T-cell therapy.

引用

页码：113 / 115

页数：3

共 50 条

[1] Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia
Diamond, Yonatan
Gilsenan, Maddie
Wang, Stacie Shiqi
Hanna, Diane
Conyers, Rachel
Cole, Theresa
Hughes, David
Fleming, Jacqueline
Meyran, Deborah
Toro, Claudia
Malalasekera, Vajiranee
Khaw, Seong Lin
Haeusler, Gabrielle M.
TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
[2] Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
Grover, Punita
Veilleux, Olivier
Tian, Lu
Sun, Ryan
Previtera, Melissa
Curran, Emily
Muffly, Lori
BLOOD ADVANCES, 2022, 6 (05) : 1608 - 1618
[3] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia
Lin, John K.
Lerman, Benjamin J.
Barnes, James I.
Boursiquot, Brian C.
Tan, Yuan Jin
Robinson, Alex Q. L.
Davis, Kara L.
Owens, Douglas K.
Goldhaber-Fiebert, Jeremy D.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (32) : 3192 - +
[4] Granulocyte Transfusions in a Patient with Relapsed B-Cell Acute Lymphoblastic Leukemia Status Post Chimeric Antigen Receptor T-Cell Therapy
Briski, Laurence M.
Siegfried, Barry
Yamada, Chisa
TRANSFUSION, 2017, 57 : 173A - 174A
[5] Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Sarkar, Reith R.
Gloude, Nicholas J.
Schiff, Deborah
Murphy, James D.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (07): : 719 - 726
[6] Chimeric antigen receptor therapy for T-cell acute lymphoblastic leukemia: finally catching up with B-cell leukemia?
Beyar-Katz, Ofrat
Rowe, Jacob M.
HAEMATOLOGICA, 2024, 109 (06) : 1631 - 1633
[7] Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia Current Landscape in 2021
Gauthier, Jordan
Turtle, Cameron J.
CANCER JOURNAL, 2021, 27 (02): : 98 - 106
[8] Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
Oh, Bernice L. Z.
Vinanica, Natasha
Wong, Desmond M. H.
Campana, Dario
HAEMATOLOGICA, 2024, 109 (06) : 1677 - 1688
[9] Allogeneic stem cell transplantation as consolidation after chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia
Cazabat, Romain
HEMATOLOGIE, 2024, 30 (05):
[10] The promise and challenges of chimeric antigen receptor T cells in relapsed B-cell acute lymphoblastic leukemia
Ding, Zhi-Chun
ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (11)

← 1 2 3 4 5 →